Skip to main content
SpringerLink
Log in

Connective Tissue Diseases in Childhood: An Approach to the Diagnosis and Classification

  • Chapter
  • First Online:
Pediatric Rheumatology

  • 1637 Accesses

Abstract

To understand how connective tissue diseases present in children

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Petty RE, Ronald M, Laxer RM, Lindsley CB. Systemic connective tissue diseases: chapter 21. In: Textbook of pediatric rheumatology. 7th ed. Philadelphia: Saunders; 2011. p. 315–465.

    Google Scholar 

  2. Foster HE. Systemic diseases: Chapter 4. In: Foster H, Brogan PA, editors. Paediatric rheumatology: Oxford specialist handbooks in pediatrics. Oxford: Oxford University Press; 2012.

    Chapter  Google Scholar 

  3. Patricia W, Laxer RM, Sherry DD. Pediatric rheumatology in clinical practice. London: Springer; 2007. p. 47–96.

    Google Scholar 

  4. Murray KJ, Adib N. Arthritis and connective tissue diseases: chapter 13.3. In: South M, Isaacs D, editors. Practical Paediatrics. Edinburgh: Elsevier; 2012. p. 453–65.

    Google Scholar 

  5. Foeldvari I. Update on juvenile systemic sclerosis. Curr Rheumatol Rep. 2015;17(3):18.

    Article  PubMed  Google Scholar 

  6. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, et al. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2004;50(5):1595–603.

    Article  PubMed  Google Scholar 

  7. Ravelli A, Davì S, Minoia F, Martini A, Cron RQ. Macrophage activation syndrome. HematolOncolClin North Am. 2015;29(5):927–4.

    Article  Google Scholar 

  8. Bennett M, Brunner HI. Biomarkers and updates on pediatrics lupus nephritis. Rheum Dis Clin North Am. 2013;39(4):833–53.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Malleson PN, Mackinnon MJ, Sailer-Hoeck M, Spencer CH. Review for the generalist: the antinuclear antibody test in children – when to use it and what to do with a positive titer. Pediatr Rheumatol Online J. 2010;8:27.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, et al. Childhood Myositis Heterogeneity Collaborative Study Group. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine. 2013;92(4):223–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Maillard SM, Jones R, Owens C, Pilkington C, Woo P, Murray KJ, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology. 2004;43(5):603–8.

    Article  CAS  PubMed  Google Scholar 

  12. Midgley A, Watson L, Beresford MW. New insights into the pathogenesis and management of lupus in children. Arch Dis Child. 2014;99(6):563–7.

    Article  CAS  PubMed  Google Scholar 

  13. James JA. Clinical perspectives on lupus genetics: advances and opportunities. Rheum Dis Clin North Am. 2014;40(3):413–32.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Aggarwal A, Srivastava P. Childhood onset systemic lupus erythematosus: how is it different from adult SLE? Int J Rheum Dis. 2015;18(2):182–91.

    Article  PubMed  Google Scholar 

  15. Mackie FE, Kainer G, Adib N, Boros C, Elliott EJ, Fahy R, et al. The national incidence and clinical picture of SLE in children in Australia – a report from the Australian Paediatric Surveillance Unit. Lupus. 2015;24(1):66–73.

    Article  CAS  PubMed  Google Scholar 

  16. Lim LS, Lefebvre A, Benseler S, Silverman ED. Longterm outcomes and damage accrual in patients with childhood systemic lupus erythematosus with psychosis and severe cognitive dysfunction. J Rheumatol. 2013;40(4):513–9.

    Article  PubMed  Google Scholar 

  17. Fonseca AR, Gaspar-Elsas MI, Land MG, de Oliveira SK. Comparison between three systems of classification criteria in juvenile systemic lupus erythematous. Rheumatology. 2015;54:241–7.

    Article  PubMed  Google Scholar 

  18. Sato VA, Marques ID, Goldenstein PT, Carmo LP, Jorge LB, et al. Lupus nephritis is more severe in children and adolescents than in older adults. Lupus. 2012;21(9):978–83.

    Article  CAS  PubMed  Google Scholar 

  19. Swart JF, Wulffraat NM. Diagnostic workup for mixed connective tissue disease in childhood. Isr Med Assoc J. 2008;10(8–9):650–2.

    PubMed  Google Scholar 

  20. Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, et al. The diagnosis and classification of mixed connective tissue disease. J Autoimmun. 2014;48–49:46–9.

    Article  PubMed  Google Scholar 

  21. Avcin T, Silverman ED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus. 2007;16(8):627–33.

    Article  CAS  PubMed  Google Scholar 

  22. Hunt BJ. Pediatric antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost. 2008;34(3):274–81.

    Article  CAS  PubMed  Google Scholar 

  23. Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am. 2007;33(2):267–85.

    Article  PubMed  Google Scholar 

  24. Izmirly PM, Buyon JP, Saxena A. Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease. Curr Opin Rheumatol. 2012;24(5):466–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Gleicher N, Elkayam U. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. Autoimmun Rev. 2013;12(11):1039–45.

    Article  CAS  PubMed  Google Scholar 

  26. Lieberman SM. Childhood Sjögren syndrome: insights from adults and animal models. Curr Opin Rheumatol. 2013;25(5):651–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Nistala K, Wedderburn LR. Update in juvenile myositis. Curr Opin Rheumatol. 2013;25(6):742–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al. Juvenile Dermatomyositis Research Group. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)—clinical characteristics of children recruited within the first 5 yr. Rheumatology. 2006;45(10):1255–60.

    Article  CAS  PubMed  Google Scholar 

  29. Ruperto N, Pistorio A, Ravelli A, Rider LG, Pilkington C, Oliveira S, et al. The PRINTO provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res. 2010;62(11):1533–41.

    Article  Google Scholar 

  30. Wedderburn LR, Rider LG. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol. 2009;23(5):665–78.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum Dis Clin North Am. 2002;28(3):603–24.

    Article  PubMed  Google Scholar 

  32. Foeldvari I. New developments in juvenile systemic and localized scleroderma. Rheum Dis Clin North Am. 2013;39(4):905–20.

    Article  PubMed  Google Scholar 

  33. Zulian F, Cuffaro G, Sperotto F. Scleroderma in children: an update. Curr Opin Rheumatol. 2013;25(5):643–50.

    Article  PubMed  Google Scholar 

  34. Rosenkranz ME, Agle LM, Efthimiou P, Lehman TJ. Systemic and localized scleroderma in children: current and future treatment options. Paediatr Drugs. 2006;8(2):85–97.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Department, Princess Margaret Hospital for Children, GPO Box D184, Perth, WA, Australia

    Kevin J. Murray MBBS, FRACP

  2. Jupiter hospital, Thane, India

    Vijay Viswanathan

Authors
  1. Kevin J. Murray MBBS, FRACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vijay Viswanathan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin J. Murray MBBS, FRACP .

Editor information

Editors and Affiliations

  1. Pediatric Rheumatology Division Institute of Child Health, Sir Ganga Ram Hospital, New Delhi, India

    Sujata Sawhney

  2. Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Amita Aggarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Murray, K.J., Viswanathan, V. (2017). Connective Tissue Diseases in Childhood: An Approach to the Diagnosis and Classification. In: Sawhney, S., Aggarwal, A. (eds) Pediatric Rheumatology. Springer, Singapore. https://doi.org/10.1007/978-981-10-1750-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1750-6_24

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1749-0

  • Online ISBN: 978-981-10-1750-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation